Dioxolane cytosine nucleosides as anti-hepatitis B agents
Open Access
- 7 September 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (17) , 2011-2014
- https://doi.org/10.1016/0960-894x(95)00343-r
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virusAntimicrobial Agents and Chemotherapy, 1995
- Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitroAntimicrobial Agents and Chemotherapy, 1994
- Synthesis and Biological Evaluation of 2',3'-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents against Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV)Journal of Medicinal Chemistry, 1994
- The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineAntimicrobial Agents and Chemotherapy, 1992
- Potent anti-HIV and anti-HBV activities of (−)-L-β-dioxolane-C and (+)-L-β-dioxolane-T and their asymmetric syntheses.Tetrahedron Letters, 1992
- Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity.Journal of Medicinal Chemistry, 1992